A detailed history of Yhb Investment Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Yhb Investment Advisors, Inc. holds 33,334 shares of ABBV stock, worth $6 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
33,334
Previous 33,420 0.26%
Holding current value
$6 Million
Previous $5.73 Million 14.83%
% of portfolio
0.56%
Previous 0.5%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$163.84 - $199.33 $14,090 - $17,142
-86 Reduced 0.26%
33,334 $6.58 Million
Q2 2024

Aug 01, 2024

SELL
$154.79 - $180.76 $182,806 - $213,477
-1,181 Reduced 3.41%
33,420 $5.73 Million
Q1 2024

Aug 14, 2024

BUY
$159.82 - $182.1 $188,747 - $215,060
1,181 Added 3.53%
34,601 $6.3 Million
Q1 2024

Apr 26, 2024

SELL
$159.82 - $182.1 $110,755 - $126,195
-693 Reduced 1.96%
34,601 $6.3 Million
Q4 2023

Jan 29, 2024

SELL
$137.6 - $154.97 $330,928 - $372,702
-2,405 Reduced 6.38%
35,294 $5.47 Million
Q3 2023

Oct 23, 2023

SELL
$133.59 - $154.65 $86,432 - $100,058
-647 Reduced 1.69%
37,699 $5.62 Million
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $244,745 - $304,570
-1,847 Reduced 4.6%
38,346 $5.17 Million
Q1 2023

May 08, 2023

BUY
$144.61 - $166.54 $135,499 - $156,047
937 Added 2.39%
40,193 $6.41 Million
Q4 2022

Jan 12, 2023

BUY
$138.31 - $165.87 $29,321 - $35,164
212 Added 0.54%
39,256 $0
Q3 2022

Nov 03, 2022

BUY
$134.21 - $153.93 $67,239 - $77,118
501 Added 1.3%
39,044 $5.24 Million
Q2 2022

Jul 14, 2022

BUY
$137.62 - $174.96 $68,947 - $87,654
501 Added 1.32%
38,543 $5.9 Million
Q1 2022

Apr 14, 2022

BUY
$131.98 - $163.75 $360,701 - $447,528
2,733 Added 7.74%
38,042 $6.17 Million
Q4 2021

Jan 18, 2022

BUY
$107.43 - $135.93 $96,042 - $121,521
894 Added 2.6%
35,309 $4.78 Million
Q3 2021

Oct 28, 2021

BUY
$106.4 - $120.78 $176,092 - $199,890
1,655 Added 5.05%
34,415 $3.71 Million
Q2 2021

Jul 15, 2021

BUY
$105.21 - $117.21 $138,982 - $154,834
1,321 Added 4.2%
32,760 $3.69 Million
Q1 2021

Apr 22, 2021

BUY
$102.3 - $112.62 $851,749 - $937,674
8,326 Added 36.02%
31,439 $3.39 Million
Q4 2020

Jan 21, 2021

BUY
$80.49 - $108.67 $43,142 - $58,247
536 Added 2.37%
23,113 $2.48 Million
Q3 2020

Nov 02, 2020

SELL
$85.91 - $100.83 $2.01 Million - $2.36 Million
-23,378 Reduced 50.87%
22,577 $1.98 Million
Q2 2020

Jul 20, 2020

BUY
$73.37 - $98.18 $20,030 - $26,803
273 Added 0.6%
45,955 $4.51 Million
Q1 2020

Apr 16, 2020

BUY
$64.5 - $97.79 $91,396 - $138,568
1,417 Added 3.2%
45,682 $3.48 Million
Q4 2019

Jan 27, 2020

SELL
$72.13 - $90.25 $73,428 - $91,874
-1,018 Reduced 2.25%
44,265 $3.92 Million
Q3 2019

Oct 15, 2019

SELL
$62.98 - $75.72 $94,910 - $114,110
-1,507 Reduced 3.22%
45,283 $3.43 Million
Q2 2019

Jul 15, 2019

SELL
$65.7 - $83.98 $67,342 - $86,079
-1,025 Reduced 2.14%
46,790 $3.4 Million
Q1 2019

Apr 29, 2019

SELL
$77.14 - $90.79 $118,024 - $138,908
-1,530 Reduced 3.1%
47,815 $3.85 Million
Q4 2018

Jan 11, 2019

SELL
$77.85 - $96.01 $14,012 - $17,281
-180 Reduced 0.36%
49,345 $4.55 Million
Q3 2018

Oct 29, 2018

SELL
$88.91 - $98.84 $10,758 - $11,959
-121 Reduced 0.24%
49,525 $4.68 Million
Q2 2018

Jul 09, 2018

BUY
$89.78 - $106.23 $2.12 Million - $2.5 Million
23,566 Added 90.36%
49,646 $4.6 Million
Q1 2018

Apr 16, 2018

BUY
$92.01 - $123.21 $13,249 - $17,742
144 Added 0.56%
26,080 $2.47 Million
Q4 2017

Jan 16, 2018

BUY
$89.56 - $98.21 $14,777 - $16,204
165 Added 0.64%
25,936 $2.51 Million
Q3 2017

Nov 06, 2017

BUY
$69.85 - $89.22 $1.8 Million - $2.3 Million
25,771
25,771 $2.29 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Yhb Investment Advisors, Inc. Portfolio

Follow Yhb Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yhb Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Yhb Investment Advisors, Inc. with notifications on news.